Solid Tumors With PIK3Ca Mutation
1 clinical trials · Condition
◉ Watch Solid Tumors With PIK3Ca Mutation
| Record | Firm | Date |
|---|---|---|
| Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors (NCT04344795) | Tempest Therapeutics | 2020-05-06 |
Track Solid Tumors With PIK3Ca Mutation automatically
Every clearance here is in the API, with alerts when new ones post.